AKT1 and diffuse large B-cell lymphoma: The PI3K/Akt pathway plays a recognized oncogenic role at the levels of survival and proliferation of DLBCL cells and tumors and PI3K is frequently activated leading to phosphorylation of downstream substrates like Akt, FKHR, and GSK3 [21].